Form 8-K - Current report:
SEC Accession No. 0001144204-16-111177
Filing Date
2016-07-01
Accepted
2016-07-01 15:38:54
Documents
1
Period of Report
2016-06-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v443567_8k.htm 8-K 13352
  Complete submission text file 0001144204-16-111177.txt   14434
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 161746786
SIC: 2836 Biological Products, (No Diagnostic Substances)